Related Experiment Video
Updated: Nov 30, 2025
08:22
Studying Copper Nanoparticle-Induced Programmed Cell Death in Bacteria
Published on: May 16, 2025
413
Copper as a potential adjunct therapy for critically ill COVID-19 patients
Shahnaz Fooladi1, Somaieh Matin2, Ata Mahmoodpoor3
1Fellowship of Critical Care Medicine, Department of Anesthesiology, School of Medicine, Ardabil University of Medical Sciences, Iran.
Clinical Nutrition ESPEN
|November 13, 2020
Summary
Copper deficiency is common in critically ill COVID-19 patients and may impact outcomes. Therapeutic copper administration warrants further investigation, balancing potential benefits against toxicity risks.
Area of Science:
- Biochemistry
- Immunology
- Virology
Background:
- COVID-19 presents a significant global health challenge with high mortality, particularly in severe cases.
- While clinical symptoms are known, the virus's pathology and cellular responses remain incompletely understood.
- Copper is vital for respiration, immune function, and antioxidant defense, yet its levels are often depleted in critically ill patients.
Purpose of the Study:
- To explore the role of copper in critically ill COVID-19 patients.
- To investigate the potential of therapeutic copper administration as a treatment strategy.
- To highlight the need for understanding copper signaling, assessment, and administration protocols.
Main Methods:
- Review of existing literature on copper's role in viral infections and critical illness.
- Analysis of copper's physiological functions and its depletion in severe disease states.
- Discussion of potential therapeutic strategies involving copper administration.
Main Results:
- Copper plays a crucial role in physiological processes and exhibits antiviral properties.
- Critically ill COVID-19 patients frequently exhibit copper depletion.
- Understanding copper's vulnerability and administration is key to its therapeutic use.
Conclusions:
- Copper insufficiency should be considered in the management of critically ill COVID-19 patients.
- Therapeutic copper administration offers a potential new avenue for treatment.
- Careful consideration of copper dosage, toxicity, and duration of imbalance is essential.
More Related Videos
Related Concept Videos
01:28Acute Coronary Syndrome IV: Interprofessional Care
114
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
114
01:22Heart Failure VI: Adjunct Therapies
127
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
127
01:26Acute Coronary Syndrome V: Nursing Management
155
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
155
01:29Acute Respiratory Failure-V
319
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
319
01:28Pneumonia IV: Management
612
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
612
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
454
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
454